Ballas Medical Ltd Filleted Accounts Cover |  |

| Ballas Medical Ltd |
|  | Company No. 09564293 |  |
|  |  | Information for Filing with The Registrar |  |  |
|  |  | 31 December 2025 |  |  |

Ballas Medical Ltd Directors Report Registrar |  |

The Director presents his report and the accounts for the period ended 31 December 2025.
Principal activities |  |  |  |  |
The principal activity of the company during the period under review was the provision of medical services.
Director |  |  |  |  |
The Director who served at any time during the period was as follows:
K. Ballas |  |  |  |  |  |  |
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board |  |  |  |
K. Ballas |  |  |  |  |  |
Director |  |  |  |  |  |
16 February 2026 |  |  |  |  |  |

Ballas Medical Ltd Balance Sheet Registrar |  |

at | 31 December 2025 |  |  |  |  |  |  |
Company No. | 09564293 |  | Notes | 2025 |  |  |  | 2025
|  |  |  |  |  | £ |  |  |  | £
Fixed assets |  |  |  |  |  |  |
| Tangible assets |  | 4 | 896 |  |  |  | 5
|  |  |  |  |  | 896 |  |  |  | 5
Current assets |  |  |  |  |  |  |
| Cash at bank and in hand |  |  | 91,092 |  |  |  | 113,917
|  |  |  |  |  | 91,092 |  |  |  | 113,917
Creditors: Amount falling due within one year | 5 | (85,179) |  |  |  | (63,843)
Net current assets |  |  | 5,913 |  |  |  | 50,074
Total assets less current liabilities |  |  | 6,809 |  |  |  | 50,079
Net assets |  |  | 6,809 |  |  |  | 50,079
Capital and reserves |  |  |  |  |  |  |
| Called up share capital |  |  | 100 |  |  |  | 100
| Profit and loss account |  | 7 | 6,709 |  |  |  | 49,979
Total equity |  |  | 6,809 |  |  |  | 50,079
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the period ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 16 February 2026 and signed on its behalf by: |  |
K. Ballas |  |  |  |  |  |  |
Director |  |  |  |  |  |  |
16 February 2026 |  |  |  |  |  |  |  |

Ballas Medical Ltd Notes to the Accounts Registrar |  |

for the period ended 31 December 2025 |  |  |  |  |  |  |  |

1 | General information |  |
| Ballas Medical Ltd is a private company limited by shares and incorporated in England and Wales.
| Its registered number is: 09564293 |  |  |  |  |  |
| Its registered office is: |  |  |  |  |  |  |  |  |  |
| Foundation House |  |  |  |  |  |  |  |  |  |
| 2-4 Forum Place |  |  |  |  |  |  |  |  |  |
| Fiddlebridge Lane |  |  |  |  |  |  |  |  |  |
| Hatfield |  |  |  |  |  |  |  |  |  |
| AL10 0RN |  |  |  |  |  |
| The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

2 | Accounting policies |  |  |  |  |  |  |  |

| Turnover |  |  |  |  |  |  |  |
| Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances. Revenue from the sale of goods is recognised when all the following conditions are satisfied: • the Company has transferred to the buyer the significant risks and rewards of ownership of the goods; • the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the economic benefits associated with the transaction will flow to the Company; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.

| Tangible fixed assets and depreciation |  |  |  |  |  |  |  |
| Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses. At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
| Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
|  | Furniture, fittings and equipment |  | 33% Straight line |  |  |  |  |  |

| Taxation |  |  |  |  |  |
| Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

| Trade and other debtors |  |  |  |  |  |  |  |
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.

| Trade and other creditors |  |  |  |  |  |  |  |
| Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

3 | Employees |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2025
|  |  |  |  |  |  |  |  |  | Number |  |  |  | Number
|  | The average monthly number of employees (including directors) during the period: | 1 |  |  |  | 1

4 | Tangible fixed assets |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  | Fixtures, fittings and equipment |  | Total
|  |  |  |  |  |  |  |  |  |  |  | £ |  | £
|  | Cost or revaluation |  |  |  |  |  |  |  |  |  |
|  | At 1 May 2025 |  |  |  |  |  |  |  | 14,251 |  | 14,251
|  | Additions |  |  |  |  |  |  |  | 1,142 |  | 1,142
|  | At 31 December 2025 |  |  |  |  |  |  |  | 15,393 |  | 15,393
|  | Depreciation |  |  |  |  |  |  |  |  |  |
|  | At 1 May 2025 |  |  |  |  |  |  |  | 14,246 |  | 14,246
|  | Charge for the year |  |  |  |  |  |  |  | 251 |  | 251
|  | At 31 December 2025 |  |  |  |  |  |  |  | 14,497 |  | 14,497
|  | Net book values |  |  |  |  |  |  |  |  |  |
|  | At 31 December 2025 |  |  |  |  |  |  |  | 896 |  | 896
|  | At 30 April 2025 |  |  |  |  |  |  |  | 5 |  | 5

5 | Creditors: |  |  |  |  |  |  |  |
|  | amounts falling due within one year |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2025
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Taxes and social security |  |  |  | 73,091 |  |  |  | 52,836
|  | Loans from directors |  |  |  | 10,588 |  |  |  | 9,327
|  | Accruals and deferred income |  |  |  | 1,500 |  |  |  | 1,680
|  |  |  |  |  |  |  |  |  | 85,179 |  |  |  | 63,843

6 | Share Capital |  |  |  |  |  |  |  |
|  | Ordinary shares

7 | Reserves |  |  |  |  |  |  |  |
|  | Profit and loss account - includes all current and prior period retained profits and losses.

8 | Dividends |  |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  | 2025 |  |  |  | 2025
|  |  |  |  |  |  |  |  |  | £ |  |  |  | £
|  | Dividends for the period: |  |  |  |  |  |  |  |
|  | Dividends paid in the period |  |  |  | 110,000 |  |  |  | 150,000
|  |  |  |  |  |  |  |  |  | 110,000 |  |  |  | 150,000
|  | Dividends by type: |  |  |  |  |  |  |  |
|  | Equity dividends |  |  |  | 110,000 |  |  |  | 150,000
|  |  |  |  |  |  |  |  |  | 110,000 |  |  |  | 150,000

Ballas Medical Ltd 09564293 31 December 2025 01 May 2025 false 16 February 2026 BTCSoftware AP Solution 2025 12.2.02 12.2.02 true 09564293 2025-05-01 2025-12-31 09564293 2025-12-31 09564293 2025-04-30 09564293 core:WithinOneYear 2025-12-31 09564293 core:WithinOneYear 2025-04-30 09564293 core:ShareCapital 2025-12-31 09564293 core:ShareCapital 2025-04-30 09564293 core:RetainedEarningsAccumulatedLosses 2025-12-31 09564293 core:RetainedEarningsAccumulatedLosses 2025-04-30 09564293 countries:UnitedKingdom 2025-05-01 2025-12-31 09564293 bus:RegisteredOffice 2025-05-01 2025-12-31 09564293 core:FurnitureFittingsToolsEquipment 2025-05-01 2025-12-31 09564293 2024-05-01 2025-04-30 09564293 core:FurnitureFittingsToolsEquipment 2025-05-01 09564293 2025-05-01 09564293 core:FurnitureFittingsToolsEquipment 2025-12-31 09564293 core:RetainedEarningsAccumulatedLosses 2025-05-01 2025-12-31 09564293 bus:AllOrdinaryShares 2025-05-01 2025-12-31 09564293 bus:SmallEntities 2025-05-01 2025-12-31 09564293 bus:FullAccounts 2025-05-01 2025-12-31 09564293 bus:AuditExempt-NoAccountantsReport 2025-05-01 2025-12-31 09564293 bus:Director1 2025-05-01 2025-12-31 09564293 bus:PrivateLimitedCompanyLtd 2025-05-01 2025-12-31 iso4217:GBP xbrli:pure